Page not found

Search results

  1. Tech Connect, Vol. 8 Issue 17: Deerfield Management and Vanderbilt University announce launch of Ancora Innovation

    ... UPCOMING EVENTS 36|86: ... of the activity that has taken place in our office over the past few weeks.   ...

    sommers - 11/28/2018 - 12:57pm

  2. Vanderbilt awarded R&D 100 Gold Medal for Evusheld, discovery of monoclonal antibodies that protect world against COVID-19

    ... gala banquet in San Diego. This is the fifth time in the past six years that Vanderbilt has received an R&D 100 award. Vanderbilt ...

    sommers - 08/26/2022 - 12:46pm

  3. Vanderbilt and 101st Airborne collaborate on development of exoskeleton for soldier use in Pathfinder Project

    ... with the 3-320th Field Artillery   During the past year, more than 100 soldiers participated in designing and testing the ...

    sommers - 08/18/2022 - 9:14am

  4. Diabetes drug study explores cardiovascular risks for patients with kidney disease

    ... 20 percent decreased risk of major adverse cardiovascular events when compared to a class of common diabetes drugs called sulfonylureas. ... associated with metformin translates as 5.8 fewer of these events per 1,000 person-years compared to sulfonylureas. The events tracked in ...

    sommers - 09/27/2019 - 10:08am

  5. Training & Education

    ... and communicating with the FDA   Current Events:       ...

    mullerg - 05/05/2023 - 4:08pm

  6. Nashville Biosciences and Illumina announce agreement to establish preeminent clinico-genomic resource for life sciences research & development

    ... Institutional Review Board (IRB)-approved process over the past 15 years. The resulting library of de-identified health and genomic ...

    sommers - 01/11/2022 - 11:06am

  7. Novel anti-platelet therapy for treatment of thrombosis, cardiovascular disease, and cerebrovascular injury

    ... minimize severe bleeding during treatment for thrombotic events. Commercial Applications Introduction of novel PAR4 ... appears to be more critical than PAR4 in adverse bleeding events linked to currently available anti-platelet therapies. Thus, these PAR4 ...

    cttc_admin - 01/23/2024 - 1:42pm

  8. Five researchers from VUMC among most highly cited

    ... Roden and Stein have made the annual list during each of the past three years. This year’s list includes 24 Nobel laureates, including ...

    sommers - 11/24/2021 - 9:05am

  9. Nyxoah and Vanderbilt University enter exclusive licensing agreement regarding next generation neurostimulation technologies to treat Obstructive Sleep Apnea (OSA)

    ... affecting almost 1 billion people globally 1 . Over the past decade, neurostimulation therapies, such as the proprietary Genio ® ...

    sommers - 02/11/2021 - 1:28pm

  10. Grant from Google to support COVID gene expression study

    ... The study will analyze blood samples collected during the past 16 years from more than 4,000 participants in the  Cameron County ...

    sommers - 09/29/2020 - 9:40am